2025-2031 Global Heparin Sodium API Industry Research & Trends Analysis Report- YH Research

日本语 | 中文

Home > Reports >Chemical & Material > 2025-2031 Global Heparin Sodium API Industry Research & Trends Analysis Report

2025-2031 Global Heparin Sodium API Industry Research & Trends Analysis Report

Publication Date: 2025-07-29
Report Id: 2355738
Industry: Chemical & Material
Report Page: 135
Chart: 136

PDF Download

Publication Date: 2025-07-29
Report Id: 2355738
Industry: Chemical & Material
Report Page: 135
Chart: 136

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Heparin Sodium API Definition
1.2 Global Heparin Sodium API Market Size and Forecast
1.2.1 By Revenue, Global Heparin Sodium API Market Size, 2020-2031
1.2.2 By Sales Volume, Global Heparin Sodium API Market Size, 2020-2031
1.2.3 Global Heparin Sodium API Price Trend, 2020-2031
1.3 China Heparin Sodium API Market Size and Forecast
1.3.1 By Revenue, China Heparin Sodium API Market Size, 2020-2031
1.3.2 By Sales Volume, China Heparin Sodium API Market Size, 2020-2031
1.3.3 China Heparin Sodium API Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Heparin Sodium API Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China Heparin Sodium API Share in Global Market, 2020-2031
1.4.3 Heparin Sodium API Market Size: China VS Global, 2020-2031
1.5 Heparin Sodium API Market Dynamics
1.5.1 Heparin Sodium API Market Drivers
1.5.2 Heparin Sodium API Market Restraints
1.5.3 Heparin Sodium API Industry Trends
1.5.4 Heparin Sodium API Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Heparin Sodium API Revenue by Company, 2020-2025
2.2 Global Heparin Sodium API Sales Volume by Company, 2020-2025
2.3 Global Heparin Sodium API Price by Company, 2020-2025
2.4 Global Heparin Sodium API Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Heparin Sodium API Concentration Ratio
2.6 Global Heparin Sodium API Mergers & Acquisitions, Expansion Plans
2.7 Global Heparin Sodium API Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Heparin Sodium API Revenue by Company, 2020-2025
3.2 China Heparin Sodium API Sales Volume by Company, 2020-2025
3.3 China Heparin Sodium API Heparin Sodium API Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Heparin Sodium API Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, Heparin Sodium API Domestic VS Export
3.6 China Market, Heparin Sodium API Import & Export
3.6.1 China Market, Heparin Sodium API Import & Export, 2020-2031
3.6.2 China Heparin Sodium API Import & Export Trends
3.6.3 Main Sources of China Heparin Sodium API Import
3.6.4 Export Destination of China Heparin Sodium API

4 Heparin Sodium API Production by Region
4.1 Global Heparin Sodium API Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of Heparin Sodium API Manufacturers
4.3 Global Major Manufacturers, Heparin Sodium API Capacity Expansion and Future Plans
4.4 Global Heparin Sodium API Capacity by Region
4.5 Global Heparin Sodium API Production by Region
4.5.1 Global Heparin Sodium API Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global Heparin Sodium API Production by Region, 2020-2025
4.5.3 Global Heparin Sodium API Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Heparin Sodium API Industry Chain
5.2 Heparin Sodium API Upstream Analysis
5.2.1 Heparin Sodium API Core Raw Materials
5.2.2 Main Manufacturers of Heparin Sodium API Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Heparin Sodium API Production Mode
5.6 Heparin Sodium API Procurement Model
5.7 Heparin Sodium API Industry Sales Model and Sales Channels
5.7.1 Heparin Sodium API Sales Model
5.7.2 Heparin Sodium API Typical Distributors

6 Sights by Product Type
6.1 Heparin Sodium API Classification
6.1.1 Unfractionated Heparin Sodium
6.1.2 Low Molecular Heparin Sodium
6.2 by Type, Global Heparin Sodium API Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Heparin Sodium API Revenue, 2020-2031
6.4 by Type, Global Heparin Sodium API Sales Volume, 2020-2031
6.5 by Type, Global Heparin Sodium API Price, 2020-2031

7 Sights by Application
7.1 Heparin Sodium API Segment by Application
7.1.1 Cardiovascular Disease
7.1.2 Dialysis Anticoagulation
7.1.3 Postoperative Thrombosis Prevention
7.1.4 Other
7.2 by Application, Global Heparin Sodium API Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Heparin Sodium API Revenue, 2020-2031
7.4 by Application, Global Heparin Sodium API Sales Volume, 2020-2031
7.5 by Application, Global Heparin Sodium API Price, 2020-2031

8 Sales Sights by Region
8.1 By Region, Global Heparin Sodium API Market Size, 2020 VS 2024 VS 2031
8.2 By Region, Global Heparin Sodium API Revenue, 2020-2031
8.3 By Region, Global Heparin Sodium API Sales Volume, 2020-2031
8.4 North America
8.4.1 North America Heparin Sodium API Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Heparin Sodium API Market Size Market Share
8.5 Europe
8.5.1 Europe Heparin Sodium API Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Heparin Sodium API Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Heparin Sodium API Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Heparin Sodium API Market Size Market Share
8.7 South America
8.7.1 South AmericaHeparin Sodium API Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Heparin Sodium API Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Heparin Sodium API Market Size & CAGR，2020 VS 2024 VS 2031
9.2 By Country, Global Heparin Sodium API Revenue, 2020-2031
9.3 By Country, Global Heparin Sodium API Sales Volume, 2020-2031
9.4 United States
9.4.1 United States Heparin Sodium API Market Size, 2020-2031
9.4.2 By Company, United States Heparin Sodium API Sales Volume Market Share, 2024
9.4.3 by Type, United States Heparin Sodium API Market Size, Share, 2024 VS 2031
9.4.4 by Application, United States Heparin Sodium API Market Size, Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Heparin Sodium API Market Size, 2020-2031
9.5.2 By Company, Europe Heparin Sodium API Sales Volume Market Share, 2024
9.5.3 by Type, Europe Heparin Sodium API Market Size, Share, 2024 VS 2031
9.5.4 by Application, Europe Heparin Sodium API Market Size, Share, 2024 VS 2031
9.6 China
9.6.1 China Heparin Sodium API Market Size, 2020-2031
9.6.2 By Company, China Heparin Sodium API Sales Volume Market Share, 2024
9.6.3 by Type, China Heparin Sodium API Market Size, Share, 2024 VS 2031
9.6.4 by Application, China Heparin Sodium API Market Size, Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Heparin Sodium API Market Size, 2020-2031
9.7.2 By Company, Japan Heparin Sodium API Market Share, 2024
9.7.3 by Type, Japan Heparin Sodium API Market Size, Share, 2024 VS 2031
9.7.4 by Application, Japan Heparin Sodium API Market Size, Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Heparin Sodium API Market Size, 2020-2031
9.8.2 By Company, South Korea Heparin Sodium API Market Share, 2024
9.8.3 by Type, South Korea Heparin Sodium API Market Size, Share, 2024 VS 2031
9.8.4 by Application, South Korea Heparin Sodium API Market Size, Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Heparin Sodium API Market Size, 2020-2031
9.9.2 By Company, Southeast Asia Heparin Sodium API Market Share, 2024
9.9.3 by Type, Southeast Asia Heparin Sodium API Market Size, Share, 2024 VS 2031
9.9.4 by Application, Southeast Asia Heparin Sodium API Market Size, Share, 2024 VS 2031
9.10 India
9.10.1 India Heparin Sodium API Market Size, 2020-2031
9.10.2 By Company, India Heparin Sodium API Market Share, 2024
9.10.3 by Type, India Heparin Sodium API Market Size, Share, 2024 VS 2031
9.10.4 by Application, India Heparin Sodium API Market Size, Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Heparin Sodium API Market Size, 2020-2031
9.11.2 By Company, Middle East & Africa Heparin Sodium API Market Share, 2024
9.11.3 by Type, Middle East & Africa Heparin Sodium API Market Size, Share, 2024 VS 2031
9.11.4 by Application, Middle East & Africa Heparin Sodium API Market Size, Share, 2024 VS 2031

10 Manufacturers Profile
10.1 Shenzhen Hepalink Pharmaceutical
10.1.1 Shenzhen Hepalink Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.1.2 Shenzhen Hepalink Pharmaceutical Heparin Sodium API Models, Specifications, and Application
10.1.3 Shenzhen Hepalink Pharmaceutical Heparin Sodium API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.1.4 Shenzhen Hepalink Pharmaceutical Company Profile and Main Business
10.1.5 Shenzhen Hepalink Pharmaceutical Recent Developments
10.2 Yantai Dongcheng Pharmaceutical
10.2.1 Yantai Dongcheng Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.2.2 Yantai Dongcheng Pharmaceutical Heparin Sodium API Models, Specifications, and Application
10.2.3 Yantai Dongcheng Pharmaceutical Heparin Sodium API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Yantai Dongcheng Pharmaceutical Company Profile and Main Business
10.2.5 Yantai Dongcheng Pharmaceutical Recent Developments
10.3 Pfizer
10.3.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.3.2 Pfizer Heparin Sodium API Models, Specifications, and Application
10.3.3 Pfizer Heparin Sodium API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.3.4 Pfizer Company Profile and Main Business
10.3.5 Pfizer Recent Developments
10.4 Bioibérica
10.4.1 Bioibérica Company Information, Head Office, Market Area, and Industry Position
10.4.2 Bioibérica Heparin Sodium API Models, Specifications, and Application
10.4.3 Bioibérica Heparin Sodium API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.4.4 Bioibérica Company Profile and Main Business
10.4.5 Bioibérica Recent Developments
10.5 Changzhou Qianhong Biopharma
10.5.1 Changzhou Qianhong Biopharma Company Information, Head Office, Market Area, and Industry Position
10.5.2 Changzhou Qianhong Biopharma Heparin Sodium API Models, Specifications, and Application
10.5.3 Changzhou Qianhong Biopharma Heparin Sodium API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.5.4 Changzhou Qianhong Biopharma Company Profile and Main Business
10.5.5 Changzhou Qianhong Biopharma Recent Developments
10.6 Nanjing King-friend Biochemical Pharmaceutical
10.6.1 Nanjing King-friend Biochemical Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.6.2 Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium API Models, Specifications, and Application
10.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.6.4 Nanjing King-friend Biochemical Pharmaceutical Company Profile and Main Business
10.6.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments
10.7 Hebei Changshan Biochemical Pharmaceutical
10.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.7.2 Hebei Changshan Biochemical Pharmaceutical Heparin Sodium API Models, Specifications, and Application
10.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Sodium API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.7.4 Hebei Changshan Biochemical Pharmaceutical Company Profile and Main Business
10.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
10.8 Qingdao Jiulong Biopharmaceutical
10.8.1 Qingdao Jiulong Biopharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.8.2 Qingdao Jiulong Biopharmaceutical Heparin Sodium API Models, Specifications, and Application
10.8.3 Qingdao Jiulong Biopharmaceutical Heparin Sodium API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.8.4 Qingdao Jiulong Biopharmaceutical Company Profile and Main Business
10.8.5 Qingdao Jiulong Biopharmaceutical Recent Developments
10.9 Opocrin
10.9.1 Opocrin Company Information, Head Office, Market Area, and Industry Position
10.9.2 Opocrin Heparin Sodium API Models, Specifications, and Application
10.9.3 Opocrin Heparin Sodium API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.9.4 Opocrin Company Profile and Main Business
10.9.5 Opocrin Recent Developments
10.10 Dongying Tiandong Pharmaceutical
10.10.1 Dongying Tiandong Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.10.2 Dongying Tiandong Pharmaceutical Heparin Sodium API Models, Specifications, and Application
10.10.3 Dongying Tiandong Pharmaceutical Heparin Sodium API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.10.4 Dongying Tiandong Pharmaceutical Company Profile and Main Business
10.10.5 Dongying Tiandong Pharmaceutical Recent Developments
10.11 Aspen Oss
10.11.1 Aspen Oss Company Information, Head Office, Market Area, and Industry Position
10.11.2 Aspen Oss Heparin Sodium API Models, Specifications, and Application
10.11.3 Aspen Oss Heparin Sodium API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.11.4 Aspen Oss Company Profile and Main Business
10.11.5 Aspen Oss Recent Developments
10.12 Yino Pharma
10.12.1 Yino Pharma Company Information, Head Office, Market Area, and Industry Position
10.12.2 Yino Pharma Heparin Sodium API Models, Specifications, and Application
10.12.3 Yino Pharma Heparin Sodium API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.12.4 Yino Pharma Company Profile and Main Business
10.12.5 Yino Pharma Recent Developments
10.13 Nanjing Xinbai Pharmaceutical
10.13.1 Nanjing Xinbai Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.13.2 Nanjing Xinbai Pharmaceutical Heparin Sodium API Models, Specifications, and Application
10.13.3 Nanjing Xinbai Pharmaceutical Heparin Sodium API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.13.4 Nanjing Xinbai Pharmaceutical Company Profile and Main Business
10.13.5 Nanjing Xinbai Pharmaceutical Recent Developments
10.14 Hubei Enoray Biopharmaceutical
10.14.1 Hubei Enoray Biopharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.14.2 Hubei Enoray Biopharmaceutical Heparin Sodium API Models, Specifications, and Application
10.14.3 Hubei Enoray Biopharmaceutical Heparin Sodium API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.14.4 Hubei Enoray Biopharmaceutical Company Profile and Main Business
10.14.5 Hubei Enoray Biopharmaceutical Recent Developments
10.15 Cisen Pharmaceutical
10.15.1 Cisen Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.15.2 Cisen Pharmaceutical Heparin Sodium API Models, Specifications, and Application
10.15.3 Cisen Pharmaceutical Heparin Sodium API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.15.4 Cisen Pharmaceutical Company Profile and Main Business
10.15.5 Cisen Pharmaceutical Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for Heparin Sodium API should grow from US$ 1201 million in 2024 to US$ 2223 million by 2031, with a CAGR of 7.1% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Heparin Sodium API

According to YH Research, the global market for Heparin Sodium API should grow from US$ 1201 million in 2024 to US$ 2223 million by 2031, with a CAGR of 7.1% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Heparin sodium API is a polysaccharide biochemical extracted from porcine intestinal mucosa, and it is called "heparin sodium" because it usually exists in the form of its sodium salt.

The Heparin Sodium API market is primarily driven by the growing global demand for anticoagulant therapies in cardiovascular and renal care. Cardiovascular disease remains the leading cause of death worldwide, necessitating large-scale use of heparin in acute coronary syndrome (ACS), myocardial infarction, and during surgical interventions like percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). Furthermore, the increasing prevalence of chronic kidney disease has led to rising dialysis procedures, where unfractionated heparin remains the standard anticoagulant to prevent clotting in extracorporeal circuits. In addition, the expanding geriatric population, which is more susceptible to thrombosis and atrial fibrillation, further fuels demand for injectable anticoagulants. On the regulatory front, a growing number of approvals for low molecular weight heparin (LMWH) formulations based on Heparin Sodium API — particularly enoxaparin — has encouraged investment by global and regional pharmaceutical manufacturers. The relatively low cost of heparin APIs, combined with established clinical efficacy, supports its continued use in both developed and emerging healthcare systems. Moreover, the concentration of raw material supply and manufacturing capacity in China provides economies of scale and stable global distribution, reinforcing market growth.

Despite favorable demand dynamics, the Heparin Sodium API market faces several critical challenges. First and foremost is the heavy dependence on animal-sourced raw materials, primarily porcine intestinal mucosa. This dependence exposes the supply chain to fluctuations in pig populations, outbreaks of diseases such as African Swine Fever (ASF), and regional farming regulations, all of which can sharply impact availability and pricing. Additionally, the limited number of GMP-compliant manufacturers with international regulatory certifications creates bottlenecks in global supply, especially during periods of surge demand or trade disruption. Another major issue is the strict quality and safety requirements enforced by regulatory authorities like the FDA and EMA, which necessitate extensive purification and viral removal steps, significantly raising production costs and compliance burdens. Lastly, growing competition from synthetic anticoagulants and direct oral anticoagulants (DOACs), which do not rely on animal tissue and offer convenient oral dosing, may gradually erode market share in certain clinical segments. These challenges underscore the need for supply diversification, technological investment, and enhanced global regulatory harmonization.

This report aims to provide a comprehensive study of the global market for Heparin Sodium API.
Report Highlights:
(1) Global Heparin Sodium API market size (sales volume & revenue), history data from 2020-2025, and forecast data from 2026 to 2031.

(2) Global Heparin Sodium API market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China Heparin Sodium API market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global Heparin Sodium API segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Heparin Sodium API segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Global major production regions of Heparin Sodium API, capacity, production and trends.

(7) Heparin Sodium API industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
Unfractionated Heparin Sodium
Low Molecular Heparin Sodium

Market segment by Application, can be divided into
Cardiovascular Disease
Dialysis Anticoagulation
Postoperative Thrombosis Prevention
Other

Market segment by players, this report covers
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Pfizer
Bioibérica
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical